The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oncology Based In-vivo CRO Market Research Report 2025
Synopsis
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible. This report focus on Oncology Based In-vivo CRO.
The global Oncology Based In-vivo CRO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oncology Based In-vivo CRO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oncology Based In-vivo CRO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Oncology Based In-vivo CRO in Pharmaceutical & Biopharmaceutical Industries is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Oncology Based In-vivo CRO include Crown Bioscience, Charles River Laboratory, ICON Plc., Eurofins Scientific, Taconic Biosciences, Covance, EVOTEC, The Jackson Laboratory and Wuxi AppTec., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oncology Based In-vivo CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Based In-vivo CRO.
Report Scope
The Oncology Based In-vivo CRO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncology Based In-vivo CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Based In-vivo CRO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Crown Bioscience
Charles River Laboratory
ICON Plc.
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
Wuxi AppTec.
MI Bioresearch, Inc.
Champion Oncology, Inc.
Xentech
Segment by Type
Blood Cancer
Solid Tumors
Other
Segment by Application
Pharmaceutical & Biopharmaceutical Industries
Medical Device Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Based In-vivo CRO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible. This report focus on Oncology Based In-vivo CRO.
The global Oncology Based In-vivo CRO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oncology Based In-vivo CRO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oncology Based In-vivo CRO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Oncology Based In-vivo CRO in Pharmaceutical & Biopharmaceutical Industries is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Oncology Based In-vivo CRO include Crown Bioscience, Charles River Laboratory, ICON Plc., Eurofins Scientific, Taconic Biosciences, Covance, EVOTEC, The Jackson Laboratory and Wuxi AppTec., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oncology Based In-vivo CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Based In-vivo CRO.
Report Scope
The Oncology Based In-vivo CRO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncology Based In-vivo CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Based In-vivo CRO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Crown Bioscience
Charles River Laboratory
ICON Plc.
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
Wuxi AppTec.
MI Bioresearch, Inc.
Champion Oncology, Inc.
Xentech
Segment by Type
Blood Cancer
Solid Tumors
Other
Segment by Application
Pharmaceutical & Biopharmaceutical Industries
Medical Device Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Based In-vivo CRO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Based In-vivo CRO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Cancer
1.2.3 Solid Tumors
1.2.4 Other
1.3 Market by Application
1.3.1 Global Oncology Based In-vivo CRO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical & Biopharmaceutical Industries
1.3.3 Medical Device Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Based In-vivo CRO Market Perspective (2019-2030)
2.2 Oncology Based In-vivo CRO Growth Trends by Region
2.2.1 Global Oncology Based In-vivo CRO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oncology Based In-vivo CRO Historic Market Size by Region (2019-2024)
2.2.3 Oncology Based In-vivo CRO Forecasted Market Size by Region (2025-2030)
2.3 Oncology Based In-vivo CRO Market Dynamics
2.3.1 Oncology Based In-vivo CRO Industry Trends
2.3.2 Oncology Based In-vivo CRO Market Drivers
2.3.3 Oncology Based In-vivo CRO Market Challenges
2.3.4 Oncology Based In-vivo CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Based In-vivo CRO Players by Revenue
3.1.1 Global Top Oncology Based In-vivo CRO Players by Revenue (2019-2024)
3.1.2 Global Oncology Based In-vivo CRO Revenue Market Share by Players (2019-2024)
3.2 Global Oncology Based In-vivo CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Based In-vivo CRO Revenue
3.4 Global Oncology Based In-vivo CRO Market Concentration Ratio
3.4.1 Global Oncology Based In-vivo CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Based In-vivo CRO Revenue in 2023
3.5 Oncology Based In-vivo CRO Key Players Head office and Area Served
3.6 Key Players Oncology Based In-vivo CRO Product Solution and Service
3.7 Date of Enter into Oncology Based In-vivo CRO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Based In-vivo CRO Breakdown Data by Type
4.1 Global Oncology Based In-vivo CRO Historic Market Size by Type (2019-2024)
4.2 Global Oncology Based In-vivo CRO Forecasted Market Size by Type (2025-2030)
5 Oncology Based In-vivo CRO Breakdown Data by Application
5.1 Global Oncology Based In-vivo CRO Historic Market Size by Application (2019-2024)
5.2 Global Oncology Based In-vivo CRO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oncology Based In-vivo CRO Market Size (2019-2030)
6.2 North America Oncology Based In-vivo CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oncology Based In-vivo CRO Market Size by Country (2019-2024)
6.4 North America Oncology Based In-vivo CRO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Based In-vivo CRO Market Size (2019-2030)
7.2 Europe Oncology Based In-vivo CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oncology Based In-vivo CRO Market Size by Country (2019-2024)
7.4 Europe Oncology Based In-vivo CRO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Based In-vivo CRO Market Size (2019-2030)
8.2 Asia-Pacific Oncology Based In-vivo CRO Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oncology Based In-vivo CRO Market Size by Region (2019-2024)
8.4 Asia-Pacific Oncology Based In-vivo CRO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Based In-vivo CRO Market Size (2019-2030)
9.2 Latin America Oncology Based In-vivo CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oncology Based In-vivo CRO Market Size by Country (2019-2024)
9.4 Latin America Oncology Based In-vivo CRO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Based In-vivo CRO Market Size (2019-2030)
10.2 Middle East & Africa Oncology Based In-vivo CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oncology Based In-vivo CRO Market Size by Country (2019-2024)
10.4 Middle East & Africa Oncology Based In-vivo CRO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Detail
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Oncology Based In-vivo CRO Introduction
11.1.4 Crown Bioscience Revenue in Oncology Based In-vivo CRO Business (2019-2024)
11.1.5 Crown Bioscience Recent Development
11.2 Charles River Laboratory
11.2.1 Charles River Laboratory Company Detail
11.2.2 Charles River Laboratory Business Overview
11.2.3 Charles River Laboratory Oncology Based In-vivo CRO Introduction
11.2.4 Charles River Laboratory Revenue in Oncology Based In-vivo CRO Business (2019-2024)
11.2.5 Charles River Laboratory Recent Development
11.3 ICON Plc.
11.3.1 ICON Plc. Company Detail
11.3.2 ICON Plc. Business Overview
11.3.3 ICON Plc. Oncology Based In-vivo CRO Introduction
11.3.4 ICON Plc. Revenue in Oncology Based In-vivo CRO Business (2019-2024)
11.3.5 ICON Plc. Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Detail
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Oncology Based In-vivo CRO Introduction
11.4.4 Eurofins Scientific Revenue in Oncology Based In-vivo CRO Business (2019-2024)
11.4.5 Eurofins Scientific Recent Development
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Detail
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Oncology Based In-vivo CRO Introduction
11.5.4 Taconic Biosciences Revenue in Oncology Based In-vivo CRO Business (2019-2024)
11.5.5 Taconic Biosciences Recent Development
11.6 Covance
11.6.1 Covance Company Detail
11.6.2 Covance Business Overview
11.6.3 Covance Oncology Based In-vivo CRO Introduction
11.6.4 Covance Revenue in Oncology Based In-vivo CRO Business (2019-2024)
11.6.5 Covance Recent Development
11.7 EVOTEC
11.7.1 EVOTEC Company Detail
11.7.2 EVOTEC Business Overview
11.7.3 EVOTEC Oncology Based In-vivo CRO Introduction
11.7.4 EVOTEC Revenue in Oncology Based In-vivo CRO Business (2019-2024)
11.7.5 EVOTEC Recent Development
11.8 The Jackson Laboratory
11.8.1 The Jackson Laboratory Company Detail
11.8.2 The Jackson Laboratory Business Overview
11.8.3 The Jackson Laboratory Oncology Based In-vivo CRO Introduction
11.8.4 The Jackson Laboratory Revenue in Oncology Based In-vivo CRO Business (2019-2024)
11.8.5 The Jackson Laboratory Recent Development
11.9 Wuxi AppTec.
11.9.1 Wuxi AppTec. Company Detail
11.9.2 Wuxi AppTec. Business Overview
11.9.3 Wuxi AppTec. Oncology Based In-vivo CRO Introduction
11.9.4 Wuxi AppTec. Revenue in Oncology Based In-vivo CRO Business (2019-2024)
11.9.5 Wuxi AppTec. Recent Development
11.10 MI Bioresearch, Inc.
11.10.1 MI Bioresearch, Inc. Company Detail
11.10.2 MI Bioresearch, Inc. Business Overview
11.10.3 MI Bioresearch, Inc. Oncology Based In-vivo CRO Introduction
11.10.4 MI Bioresearch, Inc. Revenue in Oncology Based In-vivo CRO Business (2019-2024)
11.10.5 MI Bioresearch, Inc. Recent Development
11.11 Champion Oncology, Inc.
11.11.1 Champion Oncology, Inc. Company Detail
11.11.2 Champion Oncology, Inc. Business Overview
11.11.3 Champion Oncology, Inc. Oncology Based In-vivo CRO Introduction
11.11.4 Champion Oncology, Inc. Revenue in Oncology Based In-vivo CRO Business (2019-2024)
11.11.5 Champion Oncology, Inc. Recent Development
11.12 Xentech
11.12.1 Xentech Company Detail
11.12.2 Xentech Business Overview
11.12.3 Xentech Oncology Based In-vivo CRO Introduction
11.12.4 Xentech Revenue in Oncology Based In-vivo CRO Business (2019-2024)
11.12.5 Xentech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Oncology Based In-vivo CRO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Blood Cancer
Table 3. Key Players of Solid Tumors
Table 4. Key Players of Other
Table 5. Global Oncology Based In-vivo CRO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Oncology Based In-vivo CRO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Oncology Based In-vivo CRO Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Oncology Based In-vivo CRO Market Share by Region (2019-2024)
Table 9. Global Oncology Based In-vivo CRO Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Oncology Based In-vivo CRO Market Share by Region (2025-2030)
Table 11. Oncology Based In-vivo CRO Market Trends
Table 12. Oncology Based In-vivo CRO Market Drivers
Table 13. Oncology Based In-vivo CRO Market Challenges
Table 14. Oncology Based In-vivo CRO Market Restraints
Table 15. Global Oncology Based In-vivo CRO Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Oncology Based In-vivo CRO Market Share by Players (2019-2024)
Table 17. Global Top Oncology Based In-vivo CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based In-vivo CRO as of 2023)
Table 18. Ranking of Global Top Oncology Based In-vivo CRO Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Oncology Based In-vivo CRO Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oncology Based In-vivo CRO Product Solution and Service
Table 22. Date of Enter into Oncology Based In-vivo CRO Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oncology Based In-vivo CRO Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Oncology Based In-vivo CRO Revenue Market Share by Type (2019-2024)
Table 26. Global Oncology Based In-vivo CRO Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Oncology Based In-vivo CRO Revenue Market Share by Type (2025-2030)
Table 28. Global Oncology Based In-vivo CRO Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Oncology Based In-vivo CRO Revenue Market Share by Application (2019-2024)
Table 30. Global Oncology Based In-vivo CRO Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Oncology Based In-vivo CRO Revenue Market Share by Application (2025-2030)
Table 32. North America Oncology Based In-vivo CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Oncology Based In-vivo CRO Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Oncology Based In-vivo CRO Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Oncology Based In-vivo CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Oncology Based In-vivo CRO Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Oncology Based In-vivo CRO Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Oncology Based In-vivo CRO Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Oncology Based In-vivo CRO Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Oncology Based In-vivo CRO Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Oncology Based In-vivo CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Oncology Based In-vivo CRO Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Oncology Based In-vivo CRO Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Oncology Based In-vivo CRO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Oncology Based In-vivo CRO Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Oncology Based In-vivo CRO Market Size by Country (2025-2030) & (US$ Million)
Table 47. Crown Bioscience Company Detail
Table 48. Crown Bioscience Business Overview
Table 49. Crown Bioscience Oncology Based In-vivo CRO Product
Table 50. Crown Bioscience Revenue in Oncology Based In-vivo CRO Business (2019-2024) & (US$ Million)
Table 51. Crown Bioscience Recent Development
Table 52. Charles River Laboratory Company Detail
Table 53. Charles River Laboratory Business Overview
Table 54. Charles River Laboratory Oncology Based In-vivo CRO Product
Table 55. Charles River Laboratory Revenue in Oncology Based In-vivo CRO Business (2019-2024) & (US$ Million)
Table 56. Charles River Laboratory Recent Development
Table 57. ICON Plc. Company Detail
Table 58. ICON Plc. Business Overview
Table 59. ICON Plc. Oncology Based In-vivo CRO Product
Table 60. ICON Plc. Revenue in Oncology Based In-vivo CRO Business (2019-2024) & (US$ Million)
Table 61. ICON Plc. Recent Development
Table 62. Eurofins Scientific Company Detail
Table 63. Eurofins Scientific Business Overview
Table 64. Eurofins Scientific Oncology Based In-vivo CRO Product
Table 65. Eurofins Scientific Revenue in Oncology Based In-vivo CRO Business (2019-2024) & (US$ Million)
Table 66. Eurofins Scientific Recent Development
Table 67. Taconic Biosciences Company Detail
Table 68. Taconic Biosciences Business Overview
Table 69. Taconic Biosciences Oncology Based In-vivo CRO Product
Table 70. Taconic Biosciences Revenue in Oncology Based In-vivo CRO Business (2019-2024) & (US$ Million)
Table 71. Taconic Biosciences Recent Development
Table 72. Covance Company Detail
Table 73. Covance Business Overview
Table 74. Covance Oncology Based In-vivo CRO Product
Table 75. Covance Revenue in Oncology Based In-vivo CRO Business (2019-2024) & (US$ Million)
Table 76. Covance Recent Development
Table 77. EVOTEC Company Detail
Table 78. EVOTEC Business Overview
Table 79. EVOTEC Oncology Based In-vivo CRO Product
Table 80. EVOTEC Revenue in Oncology Based In-vivo CRO Business (2019-2024) & (US$ Million)
Table 81. EVOTEC Recent Development
Table 82. The Jackson Laboratory Company Detail
Table 83. The Jackson Laboratory Business Overview
Table 84. The Jackson Laboratory Oncology Based In-vivo CRO Product
Table 85. The Jackson Laboratory Revenue in Oncology Based In-vivo CRO Business (2019-2024) & (US$ Million)
Table 86. The Jackson Laboratory Recent Development
Table 87. Wuxi AppTec. Company Detail
Table 88. Wuxi AppTec. Business Overview
Table 89. Wuxi AppTec. Oncology Based In-vivo CRO Product
Table 90. Wuxi AppTec. Revenue in Oncology Based In-vivo CRO Business (2019-2024) & (US$ Million)
Table 91. Wuxi AppTec. Recent Development
Table 92. MI Bioresearch, Inc. Company Detail
Table 93. MI Bioresearch, Inc. Business Overview
Table 94. MI Bioresearch, Inc. Oncology Based In-vivo CRO Product
Table 95. MI Bioresearch, Inc. Revenue in Oncology Based In-vivo CRO Business (2019-2024) & (US$ Million)
Table 96. MI Bioresearch, Inc. Recent Development
Table 97. Champion Oncology, Inc. Company Detail
Table 98. Champion Oncology, Inc. Business Overview
Table 99. Champion Oncology, Inc. Oncology Based In-vivo CRO Product
Table 100. Champion Oncology, Inc. Revenue in Oncology Based In-vivo CRO Business (2019-2024) & (US$ Million)
Table 101. Champion Oncology, Inc. Recent Development
Table 102. Xentech Company Detail
Table 103. Xentech Business Overview
Table 104. Xentech Oncology Based In-vivo CRO Product
Table 105. Xentech Revenue in Oncology Based In-vivo CRO Business (2019-2024) & (US$ Million)
Table 106. Xentech Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Based In-vivo CRO Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Oncology Based In-vivo CRO Market Share by Type: 2023 VS 2030
Figure 3. Blood Cancer Features
Figure 4. Solid Tumors Features
Figure 5. Other Features
Figure 6. Global Oncology Based In-vivo CRO Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Oncology Based In-vivo CRO Market Share by Application: 2023 VS 2030
Figure 8. Pharmaceutical & Biopharmaceutical Industries Case Studies
Figure 9. Medical Device Companies Case Studies
Figure 10. Others Case Studies
Figure 11. Oncology Based In-vivo CRO Report Years Considered
Figure 12. Global Oncology Based In-vivo CRO Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Oncology Based In-vivo CRO Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Oncology Based In-vivo CRO Market Share by Region: 2023 VS 2030
Figure 15. Global Oncology Based In-vivo CRO Market Share by Players in 2023
Figure 16. Global Top Oncology Based In-vivo CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based In-vivo CRO as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Oncology Based In-vivo CRO Revenue in 2023
Figure 18. North America Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Oncology Based In-vivo CRO Market Share by Country (2019-2030)
Figure 20. United States Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Oncology Based In-vivo CRO Market Share by Country (2019-2030)
Figure 24. Germany Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Oncology Based In-vivo CRO Market Share by Region (2019-2030)
Figure 32. China Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Oncology Based In-vivo CRO Market Share by Country (2019-2030)
Figure 40. Mexico Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Oncology Based In-vivo CRO Market Share by Country (2019-2030)
Figure 44. Turkey Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Oncology Based In-vivo CRO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Crown Bioscience Revenue Growth Rate in Oncology Based In-vivo CRO Business (2019-2024)
Figure 47. Charles River Laboratory Revenue Growth Rate in Oncology Based In-vivo CRO Business (2019-2024)
Figure 48. ICON Plc. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2019-2024)
Figure 49. Eurofins Scientific Revenue Growth Rate in Oncology Based In-vivo CRO Business (2019-2024)
Figure 50. Taconic Biosciences Revenue Growth Rate in Oncology Based In-vivo CRO Business (2019-2024)
Figure 51. Covance Revenue Growth Rate in Oncology Based In-vivo CRO Business (2019-2024)
Figure 52. EVOTEC Revenue Growth Rate in Oncology Based In-vivo CRO Business (2019-2024)
Figure 53. The Jackson Laboratory Revenue Growth Rate in Oncology Based In-vivo CRO Business (2019-2024)
Figure 54. Wuxi AppTec. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2019-2024)
Figure 55. MI Bioresearch, Inc. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2019-2024)
Figure 56. Champion Oncology, Inc. Revenue Growth Rate in Oncology Based In-vivo CRO Business (2019-2024)
Figure 57. Xentech Revenue Growth Rate in Oncology Based In-vivo CRO Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
